Skip to site menu Skip to page content

Daily Newsletter

18 August 2023

Daily Newsletter

18 August 2023

NIH grants $24m to set up maternal health research centres

The centres will look to address disparities in maternal health outcomes based on factors such as race, ethnicity, and age.

August 18 2023

The National Institutes of Health (NIH) has allocated $24m of initial funding to set up Maternal Health Research Centres of Excellence as part of its Implementing a Maternal Health and Pregnancy Outcomes Vision for Everyone (IMPROVE) plan.

The Maternal Health Research Centres of Excellence, which will receive grants for seven years, are set to address disparities in maternal health outcomes based on factors such as race, ethnicity, age, education, and socioeconomic status.

These centres will collaborate with community partners, including public health agencies and faith-based organisations, to research various factors impacting pregnancy-related health.

IMPROVE aims to support innovative approaches to help reduce pregnancy-related complications and deaths and also promote equity in maternal health.

NHS highlighted that the maternal death rate in the US is higher than other high-income nations, with over 1,200 such deaths recorded in 2021.

NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) director Diana W Bianchi said: “The magnitude and persistence of maternal health disparities in the United States underscore the need for research to identify evidence-based solutions to promote health equity and improve outcomes nationwide.

“Through collaborations with community partners and others, the Maternal Health Research Centres of Excellence will generate critical scientific evidence to help guide clinical care and reduce health disparities during and after pregnancy.”

The centres of excellence include ten research centres, a data innovation and coordinating hub, and a science hub.

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close